B-Thalasaemia Trait and Its Possible Cardioprotective Role

Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter

NCT00481221 ·Status: UNKNOWN

Atrial Fibrillation in Beta-Thalassemia

NCT05508932 ·Status: RECRUITING

Thrombin Generation in Beta-thalassemia Major

NCT04962984 ·Status: UNKNOWN ·Phase: NA

Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia

NCT05469230 ·Status: COMPLETED

Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects

NCT00971880 ·Status: COMPLETED

Genetic Factors Affecting the Severity of Beta Thalassemia

NCT00159042 ·Status: COMPLETED

Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major

NCT00336362 ·Status: COMPLETED ·Phase: NA

Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia

NCT05494333 ·Status: UNKNOWN

To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

NCT02626689 ·Status: COMPLETED

Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

NCT00879242 ·Status: COMPLETED ·Phase: PHASE2

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

NCT00171171 ·Status: COMPLETED ·Phase: PHASE3

Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

NCT00103753 ·Status: UNKNOWN ·Phase: PHASE4

Assessment of Cognitive Functions, Psychological Symptoms, and Quality of Life Among B Thalassemia Patients and Their Clinical Correlates.

NCT05105659 ·Status: UNKNOWN

A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

NCT05015920 ·Status: COMPLETED ·Phase: NA

Long Term Outcomes in β Thalassemia Major

NCT02307786 ·Status: COMPLETED

Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox

NCT03358498 ·Status: UNKNOWN

Thrombophilia In Beta Thalassemia

NCT04219449 ·Status: NOT_YET_RECRUITING

A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease

NCT02151526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major

NCT00800761 ·Status: COMPLETED ·Phase: PHASE4

Safety Study for Beta Thalassemia Subjects on PTG-300

NCT04054921 ·Status: COMPLETED ·Phase: PHASE2

Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?

NCT03014882 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

NCT00000623 ·Status: COMPLETED

Screening for Alpha Thalassemia in Healthy Volunteers

NCT02692872 ·Status: ACTIVE_NOT_RECRUITING

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

NCT02342145 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

NCT02906202 ·Status: COMPLETED ·Phase: PHASE3